Clinical trial
Aprospective, Randomized, Controlled Study of Amimaitosai Injection Combined With Corticosteroids for the Treatment Ofgastrointestinal Acute Graft-versus-host Disease
NCT07803978 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aprospective, Randomized, Controlled Study of Amimaitosai Injection Combined With Corticosteroids for the Treatment Ofgastrointestinal Acute Graft-versus-host Disease
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 1
- Overall status
- Enrolling by invitation
- Start date
- May 1, 2026
- Completion date
- May 1, 2029
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute gastrointestinal graft-versus-host disease